Latest Stock Market News

NCC Ltd shares fell 14.6% after reporting a 12.5% YoY drop in Q3 net profit to Rs 193.2 crore. EBITDA declined 16.6%, with margins contracting to 7.9%. Revenue rose slightly to Rs 5,344.5 crore. The stock has dropped 31.8% in six months, though analysts remain largely positive.

Manish Sonthalia highlights the shift from capex to consumption stocks post-budget. With a notable income tax saving, he predicts robust earnings growth in consumer discretionary names. Despite the muted capex outlook, sectors like IT, pharma, and insurance present attractive opportunities amidst rupee depreciation.

Cameron Brandt, Director of Research at EPFR Global, notes the current market environment is unusually frenetic due to the Trump administration s economic policies. Investors are cautious, preferring to invest in US assets while awaiting clarity. Brandt suggests the capital flow dynamics are largely a US versus emerging markets scenario, impacting countries like India.

Five stocks, including Bharti Airtel, Indus Towers, Lodha, Vodafone Idea, and NMDC, saw a long buildup on February 7, with rising open interest and stock prices, signaling bullish sentiment in the F&O segment.

Britannia Industries share price: The company s revenue from operations for Q3FY25 was Rs 4,593 crore, an 8% rise from Rs 4,256 crore a year earlier, exceeding ET Now’s forecast of Rs 4,507

The NII got impacted mainly on account of the cost of resources going up. And we believe that cost of resources, particularly on the deposit side, are peaked out. And we hope to improve the NII going forward.

Indian blue-chip indices Sensex and Nifty opened slightly lower on Friday ahead of the Reserve Bank of India s monetary policy decision. The central bank is widely anticipated to cut interest rates to bolster slowing economic growth, with the announcement expected at 10:00 a.m. IST.

Bharti Hexacom shares rose 3.8% after the company reported a 23% increase in net profit, reaching Rs 261 crore, and a 25% rise in revenue year-on-year for Q3FY25. Mobile services revenue and EBITDA margins also showed strong growth, driven by tariff adjustments and an improved revenue mix.

Aurobindo Pharma’s Q3 net profit declined 10% YoY to Rs 846 crore, despite record revenue of Rs 7,979 crore. US sales remained weak, but Europe and antiretrovirals grew. Analysts gave mixed ratings, citing profitability improvements and US market trends.